Rationale and design of a randomized clinical trial of β-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome - Lacro, Ronald V.; Dietz, Harry C.; Wruck, Lisa M.; Bradley, Timothy J.; Colan, Steven D.; Devereux, Richard B.; Klein, Gloria L.; Li, Jennifer S.; Minich, L. LuAnn; Paridon, Stephen M.; Pearson, Gail D.; Printz, Beth F.; et al. (The American heart journal, 2007)
Keywords: Adrenergic beta-Antagonists - therapeutic use; Adult; Angiotensin II Type 1 Receptor Blockers - therapeutic use; Atenolol - therapeutic use; Biological and medical sciences; Cardiology. Vascular system; Cardiovascular; Humans; Losartan - therapeutic use; Marfan Syndrome - complications; Marfan Syndrome - drug therapy; Medical sciences; Outcome Assessment, Health Care; Research Design; Human; Connective tissue disease; Therapy; Skin disease; Elastic tissue disease; Atenolol; Phlebology; Marfan syndrome; Genetic disease; Design; Goal; Randomization; Treatment; Individual; Losartan; Systemic disease; Clinical trial; Angiotensin antagonist; Circulatory system; Cardiology; Comparative study